Metric Finance
LearnFAQ
LearnFAQ

Learn / IQV

NYSE: IQV

Iqvia Holdings (IQV) stock, explained like you're 5

Iqvia Holdings trades on the New York Stock Exchange under the ticker IQV. It is a large cap company in the commercial physical & biological resarch industry, part of the healthcare sector, with a market value of about 42.8 billion dollars.

Ticker
IQV
Exchange
New York Stock Exchange
Sector
Healthcare
Industry
Commercial Physical & Biological Resarch
Size
Large cap, about 42.8 billion dollars

Is Iqvia Holdings a small, medium or large cap company?

Yes. Iqvia Holdings is a large cap stock. Its market cap, which is the total value of all its shares, is about 42.8 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Iqvia Holdings makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves IQV stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • IQVIA Holdings (IQV) Gains as Improving Demand Environment and High Win Rates (Yahoo Finance)
  • IQVIA Holdings (NYSE:IQV) Stock Price (Simply Wall Street)
  • IQVIA Holdings Inc. stock outperforms competitors on strong trading day (MarketWatch)
  • IQVIA Holdings Inc (IQV) Stock Up 3.5% but GF Value Says Overval (GuruFocus)
  • Four Veeva tools will be standard across IQVIA's clinical studies (Stock Titan)

Follow IQV in your daily brief

Each trading day at 5 PM ET we post what happened to Iqvia Holdings and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow IQV

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Iqvia Holdings stock

What does Iqvia Holdings do?

Iqvia Holdings trades on the New York Stock Exchange under the ticker IQV. It is a large cap company in the commercial physical & biological resarch industry, part of the healthcare sector, with a market value of about 42.8 billion dollars.

What is the ticker symbol for Iqvia Holdings?

Iqvia Holdings trades under the ticker IQV on the New York Stock Exchange.

What is Iqvia Holdings's market cap?

Iqvia Holdings is a large cap stock with a market cap of about 42.8 billion dollars.

How does Iqvia Holdings make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves IQV stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow IQV stock every day?

Add IQV to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow IQV daily

A free brief on Iqvia Holdings and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • INCY · Incyte
  • MEDP · Medpace Holdings
  • CRL · Charles River Laboratories International
  • ICLR · Icon PLC

Similar stocks

  • INCYIncyte
  • MEDPMedpace Holdings
  • CRLCharles River Laboratories International
  • ICLRIcon PLC

Compare IQV: IQV vs INCY, IQV vs MEDP, IQV vs CRL

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed